Part 1: MRI features of focal nodular hyperplasia with an emphasis on hepatobiliary contrast agents.

Abstract

Focal nodular hyperplasia (FNH) is the second most common benign liver tumour and typically do not require any treatment. An accurate non-invasive diagnosis is therefore vital to avoid unnecessary intervention and to reassure patients. This article discusses the demographics and pathology of FNH and reviews the appearance of FNH at MRI using liver-specific contrast agents.

• Authors: Tom Sutherland, Melanie Seale, Kelvin Yap
• Journal: Journal of medical imaging and radiation oncology (J Med Imaging Radiat Oncol) Vol. 58 Issue 1 Pg. 50-5 (Feb 2014) ISSN: 1754-9485 [Electronic] Australia
• PMID: 24171783 (Publication Type: Journal Article, Review)
• Copyright: © 2013 The Royal Australian and New Zealand College of Radiologists.

Chemical References

• Chelating Agents
• Contrast Media
• Gadolinium

Topics

• Bile Ducts (pathology)
• Chelating Agents
• Contrast Media
• Focal Nodular Hyperplasia (pathology)
• Gadolinium
• Humans
• Image Enhancement (methods)
• Liver (pathology)
• Magnetic Resonance Imaging (methods)
• Reproducibility of Results
• Sensitivity and Specificity